A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.

Published Date: 24 May 2023

A clinical trial combining two medications was recently carried out in patients with recurrent, high-grade glioblastoma (GBM) by the Mays Cancer Center at The University of Texas Health Science Center at San Antonio. Mays Cancer Center.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

automated, precise reporting for clonality testing using NGS.

2.

FDA Approves First Menin Inhibitor for Acute Leukemia

3.

Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study

4.

Antitumor mRNA-based vaccines show potential against gastric cancer metastasis

5.

Healthy weight loss could lower your odds for cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot